CONFIDENTIAL — APPROVED FOR PUBLIC RELEASE · BUREAU FILE COPY RECORDS CURRENT AS OF 29 MAY 2026 · DISTRIBUTION: UNRESTRICTED
VendorInvestigator Independent Testing Bureau · Public Records Division
DOCKET YEAR 2026 · VOL. II
35,156 SAMPLES ON FILE
No fee · No favor
Compound Evidence File
#EC-2026-0520

KissPeptin-10

Filed under Peptides. The bureau holds 146 laboratory returns for this compound from 54 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.

Cross-Index

Subjects Shipping This Compound

54 SUBJECTS
SubjectGradeSamplesMeanMinMaxFirst seenLast seen
Tianjin Finder Chemical TFCCASE #VI-2026-0693 A 8 10.0 9.9 10.0 14 Nov 2025 16 Apr 2026
WuXi TIDESCASE #VI-2026-0335 A 5 10.0 9.9 10.0 11 Nov 2025 25 Jun 2026
Shanghai ERP BiotechnologyCASE #VI-2026-0936 A 4 10.0 9.9 10.0 13 Jan 2026 6 Jul 2026
Sangon BioCASE #VI-2026-0671 A 3 10.0 9.9 10.0 23 Dec 2025 3 Jul 2026
Chinese Peptide CompanyCASE #VI-2026-0184 A 3 10.0 9.9 10.0 28 Dec 2025 3 Mar 2026
AmbioPharmCASE #VI-2026-0177 A 3 10.0 9.9 10.0 8 Apr 2026 18 Aug 2026
QYAOBIOCASE #VI-2026-0861 A 2 10.0 10.0 10.0 1 Apr 2026 1 Jun 2026
Kerui PeptidesCASE #VI-2026-0626 A 2 10.0 10.0 10.0 25 Apr 2026 27 Apr 2026
Mokemei BiotechnologyCASE #VI-2026-0540 A 2 10.0 10.0 10.0 16 Dec 2025 5 May 2026
Shanghai Sigma AudleyCASE #VI-2026-0505 A 2 10.0 10.0 10.0 10 Dec 2025 22 May 2026
Orbitrex PeptidesCASE #VI-2026-0812 X 1 10.0 10.0 10.0 3 Jun 2025 3 Jun 2025
Trusted PeptideCASE #VI-2026-0499 X 1 10.0 10.0 10.0 20 Jun 2025 20 Jun 2025
HomopeptideCASE #VI-2026-0760 A 5 9.9 9.9 10.0 24 May 2026 24 May 2026
JEEP PeptidesCASE #VI-2026-0457 A 4 9.9 9.9 10.0 5 Mar 2026 10 Jul 2026
BachemCASE #VI-2026-0314 A 4 9.9 9.9 10.0 4 Apr 2026 10 Jul 2026
Flourishglobal PeptideCASE #VI-2026-0630 A 4 9.9 9.9 10.0 10 Jan 2026 5 Jul 2026
GenScript PeptidesCASE #VI-2026-0860 A 4 9.9 9.9 10.0 26 Dec 2025 22 Jul 2026
Sigma-AldrichCASE #VI-2026-0829 A 4 9.9 9.9 10.0 27 Apr 2026 18 Aug 2026
AsymchemCASE #VI-2026-0091 A 4 9.9 9.9 10.0 14 Jun 2026 26 Jul 2026
Hybio PharmaceuticalCASE #VI-2026-0065 A 3 9.9 9.9 9.9 20 Mar 2026 12 Jul 2026
Thermo Fisher ScientificCASE #VI-2026-0142 A 3 9.9 9.9 10.0 13 Jan 2026 9 Aug 2026
SinoPepCASE #VI-2026-0387 A 3 9.9 9.9 9.9 25 Apr 2026 27 Jul 2026
Hubei JianxiangCASE #VI-2026-0048 A 2 9.9 9.9 10.0 4 Apr 2026 25 May 2026
Shanghai Wibson BiotechnologyCASE #VI-2026-0379 A 2 9.9 9.9 10.0 3 Jul 2026 8 Jul 2026
PolyPeptide GroupCASE #VI-2026-0143 A 2 9.9 9.9 10.0 23 Jul 2026 4 Aug 2026
Kerisite Shenzhen InternationalCASE #VI-2026-0315 X 1 9.3 9.3 9.3 27 Feb 2025 27 Feb 2025
Kits4lessCASE #VI-2026-0744 X 1 9.2 9.2 9.2 3 Jun 2025 3 Jun 2025
Lux Synth AminosCASE #VI-2026-0700 X 1 9.0 9.0 9.0 17 Dec 2024 17 Dec 2024
Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 A 2 8.7 8.4 8.9 25 May 2026 25 May 2026
Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 A 6 8.5 6.8 9.6 21 May 2026 21 May 2026
Qingdao Saber Technology Pharma QSTCASE #VI-2026-0467 X 1 8.4 8.4 8.4 13 Jun 2025 13 Jun 2025
Glbiochem (Shanghai)CASE #VI-2026-0704 A 7 8.3 6.9 9.8 24 May 2026 24 May 2026
Shandong Shengyuan Peptide TechnologyCASE #VI-2026-0634 X 1 8.3 8.3 8.3 3 Jul 2025 3 Jul 2025
Peptide-SCASE #VI-2026-0111 X 7 8.0 6.1 10.0 14 Jan 2025 19 Jan 2026
Qingdao Sigma Chemical QSCCASE #VI-2026-0538 A 6 7.8 6.2 9.5 24 May 2026 24 May 2026
Shanghai Sigma Audley SSACASE #VI-2026-0486 A 6 7.8 6.4 9.0 24 May 2026 24 May 2026
PeptiSlimCASE #VI-2026-0557 X 3 7.1 6.0 8.6 17 Dec 2024 20 May 2026
Bulk Peptide WholesaleCASE #VI-2026-0319 X 1 7.1 7.1 7.1 25 Apr 2025 25 Apr 2025
Laicuinuo LCNCASE #VI-2026-0223 X 1 7.1 7.1 7.1 27 Feb 2025 27 Feb 2025
M-PeptidesCASE #VI-2026-0442 X 1 6.9 6.9 6.9 3 Jun 2025 3 Jun 2025
Rayshine Peptide BiochemicalsCASE #VI-2026-0545 X 1 6.9 6.9 6.9 14 Jan 2025 14 Jan 2025
Golden EagleCASE #VI-2026-0680 X 1 6.8 6.8 6.8 27 Feb 2025 27 Feb 2025
Skye PeptidesCASE #VI-2026-0451 X 6 6.4 4.5 8.2 27 Feb 2025 21 May 2026
Peptide WorldwideCASE #VI-2026-0217 X 1 5.8 5.8 5.8 16 Mar 2025 16 Mar 2025
PurePEPSCASE #VI-2026-0552 X 1 5.5 5.5 5.5 13 Feb 2025 13 Feb 2025
Forever Young PharmacyCASE #VI-2026-0654 X 2 5.2 3.7 6.7 8 Jul 2025 25 May 2026
Pharma Grade PeptidesCASE #VI-2026-0208 X 1 4.6 4.6 4.6 21 May 2025 21 May 2025
Shenzhen Jiechuang TradingCASE #VI-2026-0292 X 1 4.6 4.6 4.6 24 Apr 2025 24 Apr 2025
Qingdao Hongshengda TradingCASE #VI-2026-0334 X 1 4.4 4.4 4.4 3 Jun 2025 3 Jun 2025
Peptides 4 ResearchCASE #VI-2026-0511 X 2 4.2 2.9 5.4 28 Mar 2025 19 Jan 2026
Biolabshop LimitedCASE #VI-2026-0832 X 1 4.2 4.2 4.2 13 Jun 2025 13 Jun 2025
Coffee and PeppersCASE #VI-2026-0274 X 1 2.2 2.2 2.2 20 Jun 2025 20 Jun 2025
Guangzhou Lengiuanhuang CosmeticsCASE #VI-2026-0228 X 1 1.7 1.7 1.7 16 Mar 2025 16 Mar 2025
Explicit SarmsCASE #VI-2026-0017 X 1 0.0 0.0 0.0 17 Dec 2024 17 Dec 2024

Open any subject to view the batch-level evidence for KissPeptin-10 alone.